Helmsley Charitable Trust Announces Transformative Partnership With Civica Foundation to Make Insulin More Affordable to Americans With Insulin-dependent Diabetes
Release Date:
03/03/2022
Using a transparent, cost-plus pricing, Civica insulins will minimize out-of-pocket expenses, particularly benefiting uninsured and underinsured Americans